Generation of chordoma cell line JHC7 and the identification of Brachyury as a novel molecular target

Laboratory investigation

Restricted access

Object

Chordoma is a malignant bone neoplasm hypothesized to arise from notochordal remnants along the length of the neuraxis. Recent genomic investigation of chordomas has identified T (Brachyury) gene duplication as a major susceptibility mutation in familial chordomas. Brachyury plays a vital role during embryonic development of the notochord and has recently been shown to regulate epithelial-to-mesenchymal transition in epithelial-derived cancers. However, current understanding of the role of this transcription factor in chordoma is limited due to the lack of availability of a fully characterized chordoma cell line expressing Brachyury. Thus, the objective of this study was to establish the first fully characterized primary chordoma cell line expressing gain of the T gene locus that readily recapitulates the original parental tumor phenotype in vitro and in vivo.

Methods

Using an intraoperatively obtained tumor sample from a 61-year-old woman with primary sacral chordoma, a chordoma cell line (JHC7, or Johns Hopkins Chordoma Line 7) was established. Molecular characterization of the primary tumor and cell line was conducted using standard immunostaining and Western blotting. Chromosomal aberrations and genomic amplification of the T gene in this cell line were determined. Using this cell line, a xenograft model was established and the histopathological analysis of the tumor was performed. Silencing of Brachyury and changes in gene expression were assessed.

Results

The authors report, for the first time, the successful establishment of a chordoma cell line (JHC7) from a patient with pathologically confirmed sacral chordoma. This cell line readily forms tumors in immunodeficient mice that recapitulate the parental tumor phenotype with conserved histological features consistent with the parental tumor. Furthermore, it is demonstrated for the first time that silencing of Brachyury using short hairpin RNA renders the morphology of chordoma cells to a more differentiated-like state and leads to complete growth arrest and senescence with an inability to be passaged serially in vitro.

Conclusions

This report represents the first xenograft model of a sacral chordoma line described in the literature and the first cell line established with stable Brachyury expression. The authors propose that Brachyury is an attractive therapeutic target in chordoma and that JHC7 will serve as a clinically relevant model for the study of this disease.

Abbreviations used in this paper: DAB = 3,3′-diaminobenzidine; DAPI = 4,6′-diamino-2-phenylindole-dihydrochloride; DMEM/F12 = Dulbecco modified Eagle medium/nutrient mixture F-12; FBS = fetal bovine serum; GAPDH = glyceraldehyde 3-phosphate dehydrogenase; HRP = horseradish peroxidase; JHC7 = Johns Hopkins Chordoma line 7; MTT = 3-(4,5-dimethylthiazol-2-yl)2,5-diphenyltetrazolium bromide; PBS = phosphate-buffered saline; PCR = polymerase chain reaction; shRNA = short hairpin RNA.
Article Information

Contributor Notes

* Drs. Hsu, Mohyeldin, and Shah contributed equally to this work.Address correspondence to: Alfredo Quiñones-Hinojosa, M.D., Brain Tumor Stem Cell & Neuro-Oncology Surgical Outcomes Laboratory, Department of Neurosurgery and Oncology, 1550 Orleans Street, Cancer Research Building II, Room 253, Baltimore, Maryland 21231. email: aquninon2@jhmi.edu.Please include this information when citing this paper: published online June 24, 2011; DOI: 10.3171/2011.5.JNS11185.

© Copyright 1944-2019 American Association of Neurological Surgeons

Headings
References
  • 1

    Boriani SBandiera SBiagini RBacchini PBoriani LCappuccio M: Chordoma of the mobile spine: fifty years of experience. Spine (Phila Pa 1976) 31:4935032006

    • Search Google Scholar
    • Export Citation
  • 2

    Casali PGMessina AStacchiotti STamborini ECrippa FGronchi A: Imatinib mesylate in chordoma. Cancer 101:208620972004

  • 3

    Choi KSCohn MJHarfe BD: Identification of nucleus pulposus precursor cells and notochordal remnants in the mouse: implications for disk degeneration and chordoma formation. Dev Dyn 237:395339582008

    • Search Google Scholar
    • Export Citation
  • 4

    DeComas AMPenfornis PHarris MRMeyer MSPochampally RR: Derivation and characterization of an extra-axial chordoma cell line (EACH-1) from a scapular tumor. J Bone Joint Surg Am 92:123112402010

    • Search Google Scholar
    • Export Citation
  • 5

    Fernando RILitzinger MTrono PHamilton DHSchlom JPalena C: The T-box transcription factor Brachyury promotes epithelial-mesenchymal transition in human tumor cells. J Clin Invest 120:5335442010

    • Search Google Scholar
    • Export Citation
  • 6

    Fourney DRRhines LDHentschel SJSkibber JMWolinsky JPWeber KL: En bloc resection of primary sacral tumors: classification of surgical approaches and outcome. J Neurosurg Spine 3:1111222005

    • Search Google Scholar
    • Export Citation
  • 7

    Gruneberg H: Genetical studies on the skeleton of the mouse. XXIII. The development of brachyury and anury. J Embryol Exp Morphol 6:4244431958

    • Search Google Scholar
    • Export Citation
  • 8

    Hashimoto KFujimoto HNakatsuji N: An ECM substratum allows mouse mesodermal cells isolated from the primitive streak to exhibit motility similar to that inside the embryo and reveals a deficiency in the T/T mutant cells. Development 100:5875981987

    • Search Google Scholar
    • Export Citation
  • 9

    Horten BCMontague SR: In vitro characteristics of a sacrococcygeal chordoma maintained in tissue and organ culture systems. Acta Neuropathol 35:13251976

    • Search Google Scholar
    • Export Citation
  • 10

    Hsieh PCXu RSciubba DMMcGirt MJNelson CWitham TF: Long-term clinical outcomes following en bloc resections for sacral chordomas and chondrosarcomas: a series of twenty consecutive patients. Spine (Phila Pa 1976) 34:223322392009

    • Search Google Scholar
    • Export Citation
  • 11

    Hsu WKosztowski TAZaidi HADorsi MGokaslan ZLWolinsky JP: Multidisciplinary management of primary tumors of the vertebral column. Curr Treat Options Oncol 10:1071252009

    • Search Google Scholar
    • Export Citation
  • 12

    Hsu WKosztowski TAZaidi HAGokaslan ZLWolinsky JP: Image-guided, endoscopic, transcervical resection of cervical chordoma. Technical note. J Neurosurg Spine 12:4314352010

    • Search Google Scholar
    • Export Citation
  • 13

    McMaster MLGoldstein AMBromley CMIshibe NParry DM: Chordoma: incidence and survival patterns in the United States, 1973–1995. Cancer Causes Control 12:1112001

    • Search Google Scholar
    • Export Citation
  • 14

    O'Donnell PTirabosco RVujovic SBartlett WBriggs TWHenderson S: Diagnosing an extra-axial chordoma of the proximal tibia with the help of brachyury, a molecule required for notochordal differentiation. Skeletal Radiol 36:59652007

    • Search Google Scholar
    • Export Citation
  • 15

    Oakley GJFuhrer KSeethala RR: Brachyury, SOX-9, and podoplanin, new markers in the skull base chordoma vs chondrosarcoma differential: a tissue microarray-based comparative analysis. Mod Pathol 21:146114692008

    • Search Google Scholar
    • Export Citation
  • 16

    Ostroumov EHunter CJ: The role of extracellular factors in human metastatic chordoma cell growth in vitro. Spine (Phila Pa 1976) 32:295729642007

    • Search Google Scholar
    • Export Citation
  • 17

    Palena CPolev DETsang KYFernando RILitzinger MKrukovskaya LL: The human T-box mesodermal transcription factor Brachyury is a candidate target for T-cellmediated cancer immunotherapy. Clin Cancer Res 13:247124782007

    • Search Google Scholar
    • Export Citation
  • 18

    Pereira BPZhou YGupta ALeong DTAung KZLing L: Runx2, p53, and pRB status as diagnostic parameters for deregulation of osteoblast growth and differentiation in a new pre-chemotherapeutic osteosarcoma cell line (OS1). J Cell Physiol 221:7787882009

    • Search Google Scholar
    • Export Citation
  • 19

    Rashbass PCooke LAHerrmann BGBeddington RS: A cell autonomous function of Brachyury in T/T embryonic stem cell chimaeras. Nature 353:3483511991

    • Search Google Scholar
    • Export Citation
  • 20

    Ricci-Vitiani LPierconti FFalchetti MLPetrucci GMaira GDe Maria R: Establishing tumor cell lines from aggressive telomerase-positive chordomas of the skull base. Technical note. J Neurosurg 105:4824842006

    • Search Google Scholar
    • Export Citation
  • 21

    Salisbury JR: The pathology of the human notochord. J Pathol 171:2532551993

  • 22

    Salisbury JRDeverell MHCookson MJWhimster WF: Three-dimensional reconstruction of human embryonic notochords: clue to the pathogenesis of chordoma. J Pathol 171:59621993

    • Search Google Scholar
    • Export Citation
  • 23

    Scheil SBrüderlein SLiehr TStarke HHerms JSchulte M: Genome-wide analysis of sixteen chordomas by comparative genomic hybridization and cytogenetics of the first human chordoma cell line, U-CH1. Genes Chromosomes Cancer 32:2032112001

    • Search Google Scholar
    • Export Citation
  • 24

    Showell CBinder OConlon FL: T-box genes in early embryogenesis. Dev Dyn 229:2012182004

  • 25

    Stacchiotti SMarrari ATamborini EPalassini EVirdis EMessina A: Response to imatinib plus sirolimus in advanced chordoma. Ann Oncol 20:188618942009

    • Search Google Scholar
    • Export Citation
  • 26

    Su YLuo XHe BCWang YChen LZuo GW: Establishment and characterization of a new highly metastatic human osteosarcoma cell line. Clin Exp Metastasis 26:5996102009

    • Search Google Scholar
    • Export Citation
  • 27

    Tirabosco RMangham DCRosenberg AEVujovic SBousdras KPizzolitto S: Brachyury expression in extra-axial skeletal and soft tissue chordomas: a marker that distinguishes chordoma from mixed tumor/myoepithelioma/parachordoma in soft tissue. Am J Surg Pathol 32:5725802008

    • Search Google Scholar
    • Export Citation
  • 28

    Vormoor JBaersch GDecker SHotfilder MSchäfer KLPelken L: Establishment of an in vivo model for pediatric Ewing tumors by transplantation into NOD/scid mice. Pediatr Res 49:3323412001

    • Search Google Scholar
    • Export Citation
  • 29

    Vujovic SHenderson SPresneau NOdell EJacques TSTirabosco R: Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas. J Pathol 209:1571652006

    • Search Google Scholar
    • Export Citation
  • 30

    Wilson VBeddington R: Expression of T protein in the primitive streak is necessary and sufficient for posterior mesoderm movement and somite differentiation. Dev Biol 192:45581997

    • Search Google Scholar
    • Export Citation
  • 31

    Yamaguchi TYamato MSaotome K: First histologically confirmed case of a classic chordoma arising in a precursor benign notochordal lesion: differential diagnosis of benign and malignant notochordal lesions. Skeletal Radiol 31:4134182002

    • Search Google Scholar
    • Export Citation
  • 32

    Yang CHornicek FJWood KBSchwab JHChoy EIafrate J: Characterization and analysis of human chordoma cell lines. Spine (Phila Pa 1976) 35:125712642010

    • Search Google Scholar
    • Export Citation
  • 33

    Yang CSchwab JHSchoenfeld AJHornicek FJWood KBNielsen GP: A novel target for treatment of chordoma: signal transducers and activators of transcription 3. Mol Cancer Ther 8:259726052009

    • Search Google Scholar
    • Export Citation
  • 34

    Yang XRNg DAlcorta DALiebsch NJSheridan ELi S: T (brachyury) gene duplication confers major susceptibility to familial chordoma. Nat Genet 41:117611782009

    • Search Google Scholar
    • Export Citation
  • 35

    Yasuda TKanamori MNogami SHori TOya TSuzuki K: Establishment of a new human osteosarcoma cell line, UTOS-1: cytogenetic characterization by array comparative genomic hybridization. J Exp Clin Cancer Res 28:262009

    • Search Google Scholar
    • Export Citation
  • 36

    York JEKaczaraj AAbi-Said DFuller GNSkibber JMJanjan NA: Sacral chordoma: 40-year experience at a major cancer center. Neurosurgery 44:74801999

    • Search Google Scholar
    • Export Citation
TrendMD
Cited By
Metrics

Metrics

All Time Past Year Past 30 Days
Abstract Views 272 271 58
Full Text Views 157 103 2
PDF Downloads 124 64 2
EPUB Downloads 0 0 0
PubMed
Google Scholar